Workflow
505(b)(2) New Drug Application
icon
搜索文档
UNCY UPCOMING DEADLINE: Levi & Korsinsky Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
Prnewswire· 2026-10-07 22:09
UNCY UPCOMING DEADLINE: Levi & Korsinsky Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm UNCY UPCOMING DEADLINE: Levi & Korsinsky Alerts Unicycive Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm Levi & Korsinsky, LLP The original CRL identified a single obstacle to approval: a contract manufacturing vendor cited for failing to adhere to current good manufacturing practices. Unicycive resubmitted its 505(b)(2) NDA in December 2025 a ...